The DOI matches its Crossref record; 237 of the 237 references it cites were found in a registry or an index.
Role of breast cancer resistance protein (BCRP/ABCG2) in cancer drug resistance
Open accessAbstract
Since cloning of the ATP-binding cassette (ABC) family member breast cancer resistance protein (BCRP/ABCG2) and its characterization as a multidrug resistance efflux transporter in 1998, BCRP has been the subject of more than two thousand scholarly articles. In normal tissues, BCRP functions as a defense mechanism against toxins and xenobiotics, with expression in the gut, bile canaliculi, placenta, blood-testis and blood-brain barriers facilitating excretion and limiting absorption of potentially toxic substrate molecules, including many cancer chemotherapeutic drugs. BCRP also plays a key role in heme and folate homeostasis, which may help normal cells survive under conditions of hypoxia. BCRP expression appears to be a characteristic of certain normal tissue stem cells termed “side population cells,” which are identified on flow cytometric analysis by their ability to exclude Hoechst 33342, a BCRP substrate fluorescent dye. Hence, BCRP expression may contribute to the natural resistance and longevity of these normal stem cells. Malignant tissues can exploit the properties of BCRP to survive hypoxia and to evade exposure to chemotherapeutic drugs. Evidence is mounting that many cancers display subpopulations of stem cells that are responsible for tumor self-renewal. Such stem cells frequently manifest the “side population” phenotype characterized by expression of BCRP and other ABC transporters. Along with other factors, these transporters may contribute to the inherent resistance of these neoplasms and their failure to be cured.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Wang, F., Xue, X., Wei, J., An, Y., Yao, J. J., Cai, H., Wu, J., Dai, C., Qian, Z., Xu, Z., et al. (2010) · British Journal of Cancer · doi:10.1038/sj.bjc.6605724 · Cited by 135
RetractedA multidrug resistance transporter from human MCF-7 breast cancer cells
Doyle, L. A., Yang, W., Abruzzo, L. V., Krogmann, T., Gao, Y., Rishi, A. K., & Ross, D. D. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.26.15665 · Cited by 2,322
Self-citationGraham, S. M., Jørgensen, H. G., Allan, E., Pearson, C., Alcorn, M. J., Richmond, L., & Holyoake, T. L. (2002) · Blood · doi:10.1182/blood.v99.1.319 · Cited by 1,181
Maliepaard, M., Scheffer, G. L., Faneyte, I. F., van Gastelen, M. A., Pijnenborg, A. C. L. M., Schinkel, A. H., van de Vijver, M. J., Scheper, R. J., & Schellens, J. H. M. (2001) · PubMed · Cited by 1,130
Miyake, K., Mickley, L. A., Litman, T., Zhan, Z., Robey, R. W., Cristensen, B., Brangi, M., Greenberger, L., Dean, M. C., Fojo, T., et al. (1999) · PubMed · Cited by 823
Jonker, J. W., Buitelaar, M., Wagenaar, E., van der Valk, M. A., Scheffer, G. L., Scheper, R. J., Plösch, T., Kuipers, F., Elferink, R. P. J. O., Rosing, H., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.202607599 · Cited by 822
Bleau, A.-M., Hambardzumyan, D., Ozawa, T., Fomchenko, E. I., Huse, J. T., Brennan, C. W., & Holland, E. C. (2009) · Cell Stem Cell · doi:10.1016/j.stem.2009.01.007 · Cited by 808
Allikmets, R., Schriml, L. M., Hutchinson, A. A., Romano-Spica, V., & Dean, M. C. (1998) · PubMed · Cited by 798
Scharenberg, C. W., Harkey, M. A., & Torok-Storb, B. (2002) · Blood · doi:10.1182/blood.v99.2.507 · Cited by 770
Bertolini, G., Roz, L., Perego, P., Tortoreto, M., Fontanella, E., Gatti, L., Pratesi, G., Fabbri, A., Andriani, F., Tinelli, S., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0905653106 · Cited by 767
Dehghan, A., Köttgen, A., Yang, Q., Hwang, S.-J., Kao, W. L., Rivadeneira, F., Boerwinkle, E., Levy, D., Hofman, A., Astor, B. C., et al. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61343-4 · Cited by 718
Allen, J. D., van Loevezijn, A., Rademaker-Lakhai, J. M., van der Valk, M., van Tellingen, O., Reid, G., Schellens, J. H. M., Koomen, G., & Schinkel, A. H. (2002) · PubMed · Cited by 704
Identification of a urate transporter, ABCG2, with a common functional polymorphism causing gout
Woodward, O. M., Köttgen, A., Coresh, J., Boerwinkle, E., Guggino, W. B., & Köttgen, M. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0901249106 · Cited by 688
The Stem Cell Marker Bcrp/ABCG2 Enhances Hypoxic Cell Survival through Interactions with Heme
Krishnamurthy, P., Ross, D. D., Nakanishi, T., Bailey-Dell, K., Zhou, S., Mercer, K. E., Sarkadi, B., Sorrentino, B. P., & Schuetz, J. D. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m313599200 · Cited by 661
Self-citationOct-4 Expression Maintained Cancer Stem-Like Properties in Lung Cancer-Derived CD133-Positive Cells
Chen, Y.-C., Hsu, H.-S., Chen, Y.-W., Tsai, T.-H., How, C.-K., Wang, C.-Y., Hung, S.-C., Chang, Y.-L., Tsai, M.-L., Lee, Y.-Y., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002637 · Cited by 508
Rabindran, S. K., Ross, D. D., Doyle, L. A., Yang, W., & Greenberger, L. M. (2000) · PubMed · Cited by 487
Self-citationRobey, R. W., To, K. K. K., Polgar, O., Dohse, M., Fetsch, P., Dean, M., & Bates, S. E. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2008.11.003 · Cited by 449
Honjo, Y., Hrycyna, C. A., Yan, Q. W., Medina-Pérez, W. Y., Robey, R. W., van de Laar, A., Litman, T., Dean, M. C., & Bates, S. E. (2001) · PubMed · Cited by 429
Localisation of breast cancer resistance protein in microvessel endothelium of human brain
Cooray, H. C., Blackmore, C. G., Maskell, L., & Barrand, M. A. (2002) · NeuroReport · doi:10.1097/00001756-200211150-00014 · Cited by 419
List, A. F., Kopecky, K. J., Willman, C. L., Head, D. R., Persons, D. L., Slovak, M. L., Dorr, R., Karanes, C., Hynes, H. E., Doroshow, J. H., et al. (2001) · Blood · doi:10.1182/blood.v98.12.3212 · Cited by 419
Burger, H., van Tol, H., Boersma, A. W. M., Brok, M., Wiemer, E. A. C., Stoter, G., & Nooter, K. (2004) · Blood · doi:10.1182/blood-2004-04-1398 · Cited by 417
Dai, C.-L., Tiwari, A. K., Wu, C.-P., Su, X.-D., Wang, S.-R., Liu, D.-G., Ashby, C. R., Huang, Y., Robey, R. W., Liang, Y.-J., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-0499 · Cited by 386
Sawadogo, D., Tolo, A., Kassi, H., Sangare, M., & Inwoley, A. (2013) · Mediterranean Journal of Hematology and Infectious Diseases · doi:10.4084/mjhid.2013.023 · Cited by 381
Jiang, X., Zhao, Y., Smith, C., Gasparetto, M., Turhan, A., Eaves, A., & Eaves, C. (2007) · Leukemia · doi:10.1038/sj.leu.2404609 · Cited by 359
Breedveld, P., Pluim, D., Cipriani, G., Wielinga, P., van Tellingen, O., Schinkel, A. H., & Schellens, J. H. M. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-2416 · Cited by 351
Pheophorbide a Is a Specific Probe for ABCG2 Function and Inhibition
Robey, R. W., Steadman, K., Polgar, O., Morisaki, K., Blayney, M., Mistry, P., & Bates, S. E. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3298 · Cited by 350
Robey, R. W., Medina-Pérez, W. Y., Nishiyama, K., Lahusen, T. J., Miyake, K., Litman, T., Senderowicz, A. M., Ross, D. D., & Bates, S. E. (2001) · PubMed · Cited by 341
Self-citationHigh-Affinity Interaction of Tyrosine Kinase Inhibitors with the ABCG2 Multidrug Transporter
Özvegy-Laczka, C., Hegedűs, T., Várady, G., Ujhelly, O., Schuetz, J. D., Váradi, A., Kéri, G., Őrfi, L., Német, K., & Sarkadi, B. (2004) · Molecular Pharmacology · doi:10.1124/mol.65.6.1485 · Cited by 340
Mi, Y.-J., Liang, Y.-J., Huang, H.-B., Zhao, H.-Y., Wu, C.-P., Wang, F., Tao, L.-Y., Zhang, C.-Z., Dai, C.-L., Tiwari, A. K., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-0111 · Cited by 337
Houghton, P. J., Germain, G. S., Harwood, F. C., Schuetz, J. D., Stewart, C. F., Buchdunger, E., & Traxler, P. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3344 · Cited by 323
Pan, Y.-Z., Morris, M. E., & Yu, A.-M. (2009) · Molecular Pharmacology · doi:10.1124/mol.108.054163 · Cited by 309
Chen, Z., Robey, R. W., Belinsky, M. G., Shchaveleva, I., Ren, X. Q., Sugimoto, Y., Ross, D. D., Bates, S. E., & Kruh, G. D. (2003) · PubMed · Cited by 305
Self-citationNakanishi, T., & Ross, D. D. (2012) · Chinese Journal of Cancer · doi:10.5732/cjc.011.10320 · Cited by 301
Self-citationOvarian cancer stem-like side-population cells are tumourigenic and chemoresistant
Hu, L., McArthur, C., & Jaffe, R. B. (2010) · British Journal of Cancer · doi:10.1038/sj.bjc.6605626 · Cited by 296
Kage, K., Tsukahara, S., Sugiyama, T., Asada, S., Ishikawa, E., Tsuruo, T., & Sugimoto, Y. (2002) · International Journal of Cancer · doi:10.1002/ijc.10100 · Cited by 291
Side population cells and Bcrp1 expression in lung
Summer, R., Kotton, D. N., Sun, X., Ma, B., Fitzsimmons, K., & Fine, A. (2003) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00009.2003 · Cited by 275
de Vries, N. A., Zhao, J., Kroon, E., Buckle, T., Beijnen, J. H., & van Tellingen, O. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-1335 · Cited by 270
Characterization of Oligomeric Human Half-ABC Transporter ATP-binding Cassette G2
Xu, J., Liu, Y., Yang, Y., Bates, S., & Zhang, J.-T. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m310785200 · Cited by 267
Kodaira, H., Kusuhara, H., Ushiki, J., Fuse, E., & Sugiyama, Y. (2010) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.109.162321 · Cited by 266
Adhikari, A. S., Agarwal, N., Wood, B. M., Porretta, C., Ruiz, B., Pochampally, R. R., & Iwakuma, T. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-3463 · Cited by 261
The role of transporters in cellular heme and porphyrin homeostasis
KRISHNAMURTHY, P., XIE, T., & SCHUETZ, J. (2007) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2007.02.001 · Cited by 260
Polli, J. W., Olson, K. L., Chism, J. P., John-Williams, L. S., Yeager, R. L., Woodard, S. M., Otto, V., Castellino, S., & Demby, V. E. (2009) · Drug Metabolism and Disposition · doi:10.1124/dmd.108.024646 · Cited by 256
Agarwal, S., Sane, R., Gallardo, J. L., Ohlfest, J. R., & Elmquist, W. F. (2010) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.110.167601 · Cited by 255
Overexpression of wild-type breast cancer resistance protein mediates methotrexate resistance.
Volk, E. L., Farley, K. M., Wu, Y. F., Li, F., Robey, R. W., & Schneider, E. (2002) · PubMed · Cited by 248
Yoh, K., Ishii, G., Yokose, T., Minegishi, Y., Tsuta, K., Goto, K., Nishiwaki, Y., Kodama, T., Suga, M., & Ochiai, A. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-0937-3 · Cited by 242
Wang, X. Q., Ongkeko, W. M., Chen, L., Yang, Z. F., Lu, P., Chen, K. K., Lopez, J. P., Poon, R. T. P., & Fan, S. T. (2010) · Hepatology · doi:10.1002/hep.23692 · Cited by 238
Cyclosporin A Is a Broad-Spectrum Multidrug Resistance Modulator
Qadir, M., O'Loughlin, K. L., Fricke, S. M., Williamson, N. A., Greco, W. R., Minderman, H., & Baer, M. R. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-1725 · Cited by 236
Self-citationAlvarez, A. I., Real, R., Pérez, M., Mendoza, G., Prieto, J. G., & Merino, G. (2010) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21851 · Cited by 235
Mechanism of the Pharmacokinetic Interaction between Methotrexate and Benzimidazoles
Breedveld, P., Zelcer, N., Pluim, D., Sönmezer, O., Tibben, M. M., Beijnen, J. H., Schinkel, A. H., van Tellingen, O., Borst, P., & Schellens, J. H. M. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-4062 · Cited by 233
Maliepaard, M., van Gastelen, M. A., Tohgo, A., Hausheer, F. H., van Waardenburg, R. C. A. M., de Jong, L. A., Pluim, D., Beijnen, J. H., & Schellens, J. H. M. (2001) · PubMed · Cited by 231
Hegedűs, C., Özvegy‐Laczka, C., Apáti, Á., Magócsi, M., Német, K., Őrfi, L., Kéri, G., Katona, M., Takáts, Z., Váradi, A., et al. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00383.x · Cited by 228
Steinbach, D., Sell, W., Voigt, A., Hermann, J., Zintl, F., & Sauerbrey, A. (2002) · Leukemia · doi:10.1038/sj.leu.2402541 · Cited by 226
Bailey-Dell, K. J., Hassel, B., Doyle, L. A., & Ross, D. D. (2001) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/s0167-4781(01)00270-6 · Cited by 225
Self-citationKiyotani, K., Mushiroda, T., Imamura, C. K., Hosono, N., Tsunoda, T., Kubo, M., Tanigawara, Y., Flockhart, D. A., Desta, Z., Skaar, T. C., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.25.7246 · Cited by 225
Shukla, S., Robey, R. W., Bates, S. E., & Ambudkar, S. V. (2009) · Drug Metabolism and Disposition · doi:10.1124/dmd.108.024612 · Cited by 225
Chen, Y. N., Mickley, L. A., Schwartz, A. M., Acton, E. M., Hwang, J. L., & Fojo, A. T. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)38781-2 · Cited by 221
Ee, P. L. R., Kamalakaran, S., Tonetti, D., He, X., Ross, D. D., & Beck, W. T. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3583 · Cited by 217
Self-citationDohse, M., Scharenberg, C., Shukla, S., Robey, R. W., Volkmann, T., Deeken, J. F., Brendel, C., Ambudkar, S. V., Neubauer, A., & Bates, S. E. (2010) · Drug Metabolism and Disposition · doi:10.1124/dmd.109.031302 · Cited by 216
Ma, Y., Cui, W., Yang, J., Qu, J., Di, C., Amin, H. M., Lai, R., Ritz, J., Krause, D. S., & Chai, L. (2006) · Blood · doi:10.1182/blood-2006-02-001594 · Cited by 215
Wild-type breast cancer resistance protein (BCRP/ABCG2) is a methotrexate polyglutamate transporter.
Volk, E. L., & Schneider, E. (2003) · PubMed · Cited by 215
Tiwari, A. K., Sodani, K., Wang, S.-R., Kuang, Y.-H., Ashby, C. R., Chen, X., & Chen, Z.-S. (2009) · Biochemical Pharmacology · doi:10.1016/j.bcp.2009.04.002 · Cited by 209
Dasatinib Cellular Uptake and Efflux in Chronic Myeloid Leukemia Cells: Therapeutic Implications
Hiwase, D. K., Saunders, V., Hewett, D., Frede, A., Zrim, S., Dang, P., Eadie, L., To, L. B., Melo, J., Kumar, S., et al. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-5095 · Cited by 208
Gefitinib Enhances the Antitumor Activity and Oral Bioavailability of Irinotecan in Mice
Stewart, C. F., Leggas, M., Schuetz, J. D., Panetta, J. C., Cheshire, P. J., Peterson, J., Daw, N., Jenkins, J. J., Gilbertson, R., Germain, G. S., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0096 · Cited by 203
Intestinal efflux transporters and drug absorption
Murakami, T., & Takano, M. (2008) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.4.7.923 · Cited by 201
Marchetti, S., de Vries, N. A., Buckle, T., Bolijn, M. J., van Eijndhoven, M. A. J., Beijnen, J. H., Mazzanti, R., van Tellingen, O., & Schellens, J. H. M. (2008) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-07-2250 · Cited by 201
Brendel, C., Scharenberg, C., Dohse, M., Robey, R. W., Bates, S. E., Shukla, S., Ambudkar, S. V., Wang, Y., Wennemuth, G., Burchert, A., et al. (2007) · Leukemia · doi:10.1038/sj.leu.2404638 · Cited by 200
P-glycoprotein and Breast Cancer Resistance Protein Influence Brain Distribution of Dasatinib
Chen, Y., Agarwal, S., Shaik, N. M., Chen, C., Yang, Z., & Elmquist, W. F. (2009) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.109.154781 · Cited by 194
Allen, J. D., & Schinkel, A. H. (2002) · PubMed · Cited by 193
Singh, A., Wu, H., Zhang, P., Happel, C., Ma, J., & Biswal, S. (2010) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-10-0108 · Cited by 192
Huang, W.-C., Chen, Y.-J., Li, L.-Y., Wei, Y.-L., Hsu, S.-C., Tsai, S.-L., Chiu, P.-C., Huang, W.-P., Wang, Y.-N., Chen, C.-H., et al. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.240796 · Cited by 190
Subcellular Localization and Activity of Multidrug Resistance Proteins
Rajagopal, A., & Simon, S. M. (2003) · Molecular Biology of the Cell · doi:10.1091/mbc.e02-11-0704 · Cited by 190
Xie, Y., Xu, K., Linn, D. E., Yang, X., Guo, Z., Shimelis, H., Nakanishi, T., Ross, D. D., Chen, H., Fazli, L., et al. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m707773200 · Cited by 189
Self-citationABCG2 expression, function, and promoter methylation in human multiple myeloma
Turner, J. G., Gump, J. L., Zhang, C., Cook, J. M., Marchion, D., Hazlehurst, L., Munster, P., Schell, M. J., Dalton, W. S., & Sullivan, D. M. (2006) · Blood · doi:10.1182/blood-2005-10-009084 · Cited by 189
Breast Cancer Resistance Protein and P-Glycoprotein in 149 Adult Acute Myeloid Leukemias
Benderra, Z., Faussat, A.-M., Sayada, L., Perrot, J.-Y., Chaoui, D., Marie, J.-P., & Legrand, O. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0795 · Cited by 188
Kim, D. H. (., Sriharsha, L., Xu, W., Kamel-Reid, S., Liu, X., Siminovitch, K., Messner, H. A., & Lipton, J. H. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-0145 · Cited by 186
Breast Cancer Resistance Protein and P-glycoprotein Limit Sorafenib Brain Accumulation
Lagas, J. S., van Waterschoot, R. A. B., Sparidans, R. W., Wagenaar, E., Beijnen, J. H., & Schinkel, A. H. (2010) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-09-0663 · Cited by 185
Poller, B., Drewe, J., Krähenbühl, S., Huwyler, J., & Gutmann, H. (2010) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-009-9431-1 · Cited by 184
Szatmari, I., Vámosi, G., Brazda, P., Balint, B. L., Benko, S., Széles, L., Jeney, V., Özvegy-Laczka, C., Szántó, A., Barta, E., et al. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m604890200 · Cited by 180
Sildenafil Reverses ABCB1- and ABCG2-Mediated Chemotherapeutic Drug Resistance
Shi, Z., Tiwari, A. K., Shukla, S., Robey, R. W., Singh, S., Kim, I.-W., Bates, S. E., Peng, X., Abraham, I., Ambudkar, S. V., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-3820 · Cited by 170
Tang, S. C., Lagas, J. S., Lankheet, N. A. G., Poller, B., Hillebrand, M. J., Rosing, H., Beijnen, J. H., & Schinkel, A. H. (2012) · International Journal of Cancer · doi:10.1002/ijc.26000 · Cited by 165
To, K. K. W., Zhan, Z., Litman, T., & Bates, S. E. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.00331-08 · Cited by 164
Bart, J., Hollema, H., Groen, H. J. M., de Vries, E. G. E., Hendrikse, N. H., Sleijfer, D. T., Wegman, T. D., Vaalburg, W., & van der Graaf, W. T. A. (2004) · European Journal of Cancer · doi:10.1016/j.ejca.2004.05.010 · Cited by 164
ABCG2: the key to chemoresistance in cancer stem cells?
An, Y., & Ongkeko, W. M. (2009) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425250903228834 · Cited by 162
Agarwal, S., Sane, R., Ohlfest, J. R., & Elmquist, W. F. (2011) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.110.175034 · Cited by 162
Akt Signaling Regulates Side Population Cell Phenotype via Bcrp1 Translocation
Mogi, M., Yang, J., Lambert, J.-F., Colvin, G. A., Shiojima, I., Skurk, C., Summer, R., Fine, A., Quesenberry, P. J., & Walsh, K. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m306362200 · Cited by 161
Singh, R. R., Kunkalla, K., Qu, C., Schlette, E. J., Neelapu, S. S., Samaniego, F., & Vega, F. (2011) · Oncogene · doi:10.1038/onc.2011.195 · Cited by 161
de Vries, N. A., Buckle, T., Zhao, J., Beijnen, J. H., Schellens, J. H. M., & van Tellingen, O. (2012) · Investigational New Drugs · doi:10.1007/s10637-010-9569-1 · Cited by 158
Functional ABCG2 is overexpressed on primary CML CD34+ cells and is inhibited by imatinib mesylate
Jordanides, N. E., Jorgensen, H. G., Holyoake, T. L., & Mountford, J. C. (2006) · Blood · doi:10.1182/blood-2006-02-003145 · Cited by 158
Narang, V. S., Fraga, C. H., Kumar, N., Shen, J., Throm, S. L., Stewart, C. F., & Waters, C. M. (2008) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00491.2007 · Cited by 157
Shi, G., Xu, Y., Fan, J., Zhou, J., Yang, X., Qiu, S., Liao, Y., Wu, W., Ji, Y., Ke, A., et al. (2008) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-008-0407-1 · Cited by 156
Jakubíková, J., Adamia, S., Kost‐Alimova, M., Klippel, S., Cervi, D. N., Daley, J. F., Cholujová, D., Kong, S., Leiba, M., Blotta, S., et al. (2011) · Blood · doi:10.1182/blood-2010-02-267344 · Cited by 154
Fang, D. D., Kim, Y. J., Lee, C. N., Aggarwal, S., McKinnon, K. M., Mesmer, D., Norton, J., Birse, C. E., He, T., Ruben, S. M., et al. (2010) · British Journal of Cancer · doi:10.1038/sj.bjc.6605610 · Cited by 154
MRP3, BCRP, and P-Glycoprotein Activities are Prognostic Factors in Adult Acute Myeloid Leukemia
Benderra, Z., Faussat, A. M., Sayada, L., Perrot, J., Tang, R., Chaoui, D., Morjani, H., Marzac, C., Marie, J., & Legrand, O. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-1895 · Cited by 154
Salcido, C. D., Larochelle, A., Taylor, B. J., Dunbar, C. E., & Varticovski, L. (2010) · British Journal of Cancer · doi:10.1038/sj.bjc.6605668 · Cited by 153
Kuo, M. T. (2008) · Antioxidants and Redox Signaling · doi:10.1089/ars.2008.2095 · Cited by 152
Nakanishi, T., Shiozawa, K., Hassel, B. A., & Ross, D. D. (2006) · Blood · doi:10.1182/blood-2005-10-4020 · Cited by 148
Self-citationZhou, L., Schmidt, K., Nelson, F. R., Zelesky, V., Troutman, M. D., & Feng, B. (2009) · Drug Metabolism and Disposition · doi:10.1124/dmd.108.024489 · Cited by 147
Chikazawa, N., Tanaka, H., Tasaka, T., Nakamura, M., Tanaka, M., Onishi, H., & Katano, M. (2010) · PubMed · Cited by 147
Chen, H., Li, H., Li, J., Zhu, Z. G., Yin, S., Hao, X., Yao, M., Zheng, S.-S., & Gu, J. (2008) · Carcinogenesis · doi:10.1093/carcin/bgn223 · Cited by 146
Isolation and Identification of Cancer Stem-Like Cells in Esophageal Carcinoma Cell Lines
Huang, D., Gao, Q., Guo, L., Zhang, C., Jiang, W. B., Li, H., Wang, J., Xiao-hong, H., Shi, Y., & Lu, S. (2008) · Stem Cells and Development · doi:10.1089/scd.2008.0033 · Cited by 140
Wulf, G. G., Luo, K.-L., Jackson, K. A., Brenner, M. K., & Goodell, M. A. (2003) · PubMed · Cited by 139
Mahller, Y. Y., Williams, J. P., Baird, W. H., Mitton, B. A., Grossheim, J. M., Saeki, Y., Cancelas, J. A., Ratner, N., & Cripe, T. P. (2009) · PLoS ONE · doi:10.1371/journal.pone.0004235 · Cited by 138
Oostendorp, R. L., Buckle, T., Beijnen, J. H., van Tellingen, O., & Schellens, J. H. M. (2008) · Investigational New Drugs · doi:10.1007/s10637-008-9138-z · Cited by 137
Characterization of a stem cell population in lung cancer A549 cells
Sung, J.-M., Cho, H., Yi, H., Lee, C.-H., Kim, H., Kim, D., El‐Aty, A. M. A., Kim, J.-S., Landowski, C. P., Hediger, M. A., et al. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.04.038 · Cited by 135
Pharmacogenetics of Membrane Transporters: An Update on Current Approaches
Sissung, T. M., Baum, C. E., Kirkland, C. T., Gao, R., Gardner, E. R., & Figg, W. D. (2009) · Molecular Biotechnology · doi:10.1007/s12033-009-9220-6 · Cited by 134
Martin, C. M., Ferdous, A., Gallardo, T., Humphries, C., Sadek, H., Caprioli, A., Garcia, J. A., Szweda, L. I., Garry, M. G., & Garry, D. J. (2008) · Circulation Research · doi:10.1161/circresaha.107.161729 · Cited by 133
van der Kolk, D. M., Vellenga, E., Scheffer, G. L., Müller, M. M., Bates, S. E., Scheper, R. J., & de Vries, E. G. E. (2002) · Blood · doi:10.1182/blood.v99.10.3763 · Cited by 133
Purification and 3D Structural Analysis of Oligomeric Human Multidrug Transporter ABCG2
McDevitt, C. A., Collins, R. F., Conway, M. A., Modok, S., Storm, J., Kerr, I. D., Ford, R. C., & Callaghan, R. (2006) · Structure · doi:10.1016/j.str.2006.08.014 · Cited by 132
The ABCG2 resistance network of glioblastoma.
Bleau, A., Huse, J. T., & Holland, E. C. (2009) · PubMed · Cited by 129
Calcagno, A. M., Fostel, J. M., To, K. K. W., Salcido, C. D., Martin, S. E., Chewning, K. J., Wu, C.-P., Varticovski, L., Bates, S. E., Caplen, N. J., et al. (2008) · British Journal of Cancer · doi:10.1038/sj.bjc.6604334 · Cited by 128
Aberrant Promoter Methylation of the ABCG2 Gene in Renal Carcinoma
To, K. K. W., Zhan, Z., & Bates, S. E. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.00650-06 · Cited by 126
The ABCG2 resistance network of glioblastoma
Bleau, A., Huse, J. T., & Holland, E. C. (2009) · Cell Cycle · doi:10.4161/cc.8.18.9504 · Cited by 126
Damiani, D., Tiribelli, M., Calistri, E., Geromin, A., Chiarvesio, A., Michelutti, A., Cavallin, M., & Fanin, R. (2006) · PubMed · Cited by 125
To, K. K. W., Polgár, O., Huff, L. M., Morisaki, K., & Bates, S. E. (2008) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-07-0175 · Cited by 125
Ota, S., Ishii, G., Goto, K., Kubota, K., Kim, Y. H., Kojika, M., Murata, Y., Yamazaki, M., Nishiwaki, Y., Eguchi, K., et al. (2008) · Lung Cancer · doi:10.1016/j.lungcan.2008.07.014 · Cited by 123
Low levels of ABCG2 expression in adult AML blast samples
Abbott, B. L., Colapietro, A.-M., Barnes, Y., Marini, F. C., Andreeff, M., & Sorrentino, B. P. (2002) · Blood · doi:10.1182/blood-2002-01-0271 · Cited by 121
Liu, T., Xu, F., Du, X., Lai, D., Liu, T., Zhao, Y., Huang, Q. M., Jiang, L., Huang, W., Cheng, W., et al. (2010) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-010-0426-5 · Cited by 120
Henriksen, U., Fog, J. U., Litman, T., & Gether, U. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m502937200 · Cited by 119
Expression of Protein Tyrosine Kinases in Head and Neck Squamous Cell Carcinomas
Ongkeko, W. M., Altuna, X., Weisman, R. A., & Wang‐Rodriguez, J. (2005) · American Journal of Clinical Pathology · doi:10.1309/btln-5wtm-j3pc-nrrc · Cited by 117
Li, X., Pan, Y.-Z., Seigel, G. M., Hu, Z.-H., Huang, M., & Yu, A. (2011) · Biochemical Pharmacology · doi:10.1016/j.bcp.2010.12.018 · Cited by 116
Wang, H., Lee, E., Zhou, L., Leung, P. C. K., Ross, D. D., Unadkat, J. D., & Mao, Q. (2007) · Molecular Pharmacology · doi:10.1124/mol.107.041087 · Cited by 116
Self-citationDiop, N. K., & Hrycyna, C. A. (2005) · Biochemistry · doi:10.1021/bi0479858 · Cited by 114
Escape from hsa-miR-519c enables drug-resistant cells to maintain high expression of ABCG2
To, K. K. W., Robey, R. W., Knutsen, T., Zhan, Z., Ried, T., & Bates, S. E. (2009) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-09-0292 · Cited by 112
Elmeliegy, M. A., Carcaboso, A. M., Tagen, M., Bai, F., & Stewart, C. F. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-1934 · Cited by 112
Novel Extracellular Vesicles Mediate an ABCG2-Dependent Anticancer Drug Sequestration and Resistance
Ifergan, I., Scheffer, G. L., & Assaraf, Y. G. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-2021 · Cited by 110
Joerger, M., Huitema, A. D. R., van den Bongard, H. J. G. D., et al. (2005) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2005.02513.x · Cited by 107
Hauswald, S., Duque‐Afonso, J., Wagner, M. M., Schertl, F. M., Lübbert, M., Peschel, C., Keller, U. B., & Licht, T. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-2048 · Cited by 107
WANG, Y., Li, F., LUO, B., Wang, X., Sun, H., LIU, S., Cui, Y., & Xu, X. (2009) · Neoplasma · doi:10.4149/neo_2009_05_371 · Cited by 106
Raaijmakers, M. H. G. P., de Grouw, E. P. L. M., Heuver, L. H. H., van der Reijden, B. A., Jansen, J. H., Scheper, R. J., Scheffer, G. L., de Witte, T. J. M., & Raymakers, R. A. P. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0212 · Cited by 106
ABCG2 Transports and Transfers Heme to Albumin through Its Large Extracellular Loop*
Mandon, E. D., Arnaud, O., Martinez, L., Huché, F., Pietro, A. D., & Falson, P. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.139170 · Cited by 104
Nakanishi, T., Chumsri, S., Khakpour, N., Brodie, A., Leyland-Jones, B., Hamburger, A. W., Ross, D. D., & Burger, A. M. (2010) · British Journal of Cancer · doi:10.1038/sj.bjc.6605553 · Cited by 104
Self-citationStructure and Function of ABCG2-Rich Extracellular Vesicles Mediating Multidrug Resistance
Goler-Baron, V., & Assaraf, Y. G. (2011) · PLoS ONE · doi:10.1371/journal.pone.0016007 · Cited by 104
BCRP mRNA expression v. clinical outcome in 40 adult AML patients
Uggla, B., Ståhl, E., Wågsäter, D., Paul, C., Karlsson, M. G., Sirsjö, A., & Tidefelt, U. (2004) · Leukemia Research · doi:10.1016/j.leukres.2004.06.004 · Cited by 103
Takada, T., Suzuki, H., Gotoh, Y., & Sugiyama, Y. (2005) · Drug Metabolism and Disposition · doi:10.1124/dmd.104.003228 · Cited by 102
Lapatinib and erlotinib are potent reversal agents for MRP7 (ABCC10)-mediated multidrug resistance
Kuang, Y., Shen, T., Chen, X. '., Sodani, K. S., Hopper-Borge, E. A., Tiwari, A. K., Lee, J. W. K. K., Fu, L., & Chen, Z. (2009) · Biochemical Pharmacology · doi:10.1016/j.bcp.2009.08.021 · Cited by 100
Ho, M., Hogge, D. E., & Ling, V. W. T. (2008) · Experimental Hematology · doi:10.1016/j.exphem.2007.11.014 · Cited by 99
Slomiany, M. G., Dai, L., Bomar, P. A., Knackstedt, T., Kranc, D. A., Tolliver, L. B., Maria, B. L., & Toole, B. P. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-0143 · Cited by 99
Expression of the BCRP gene (ABCG2/MXR/ABCP) in childhood acute lymphoblastic leukaemia
Sauerbrey, A., Sell, W., Steinbach, D., Voigt, A., & Zintl, F. (2002) · British Journal of Haematology · doi:10.1046/j.1365-2141.2002.03550.x · Cited by 97
Nakagawa, H., Wakabayashi‐Nakao, K., Tamura, A., Toyoda, Y., Koshiba, S., & Ishikawa, T. (2009) · FEBS Journal · doi:10.1111/j.1742-4658.2009.07423.x · Cited by 95
Nuclear Factor (Erythroid-Derived 2)-Like 2 Regulates Drug Resistance in Pancreatic Cancer Cells
Hong, Y. B., Kang, H. J., Kwon, S. Y., Kim, H. J., Kwon, K. Y., Cho, C. H., Lee, J., Kallakury, B., & Bae, I. (2010) · Pancreas · doi:10.1097/mpa.0b013e3181c31314 · Cited by 95
Emerging role for drug transporters at the blood–testis barrier
Mruk, D. D., Su, L., & Cheng, C. Y. (2010) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2010.11.007 · Cited by 95
In vivo investigation of CD133 as a putative marker of cancer stem cells in Hep‐2 cell line
Xu, W. D., Zhou, L. F., Cheng, L., Tian, J., Jiang, J. J., & MacCallum, J. K. (2008) · Head & Neck · doi:10.1002/hed.20935 · Cited by 95
Fiore, R. D., Santulli, A., Ferrante, R. D., Giuliano, M., Blasio, A. D., Messina, C. M., Pirozzi, G., Tirino, V., Tesoriere, G., & Vento, R. (2009) · Journal of Cellular Physiology · doi:10.1002/jcp.21667 · Cited by 94
Kourti, M., Vavatsi, N. A., Gombakis, N., Sidi, V., Tzimagiorgis, G., Papageorgiou, T., Koliouskas, D. E., & Athanassiadou, F. (2007) · International Journal of Hematology · doi:10.1532/ijh97.e0624 · Cited by 93
Pradhan, M., Bembinster, L. A., Baumgarten, S. C., & Frasor, J. M. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.155309 · Cited by 92
SALL4 is a robust stimulator for the expansion of hematopoietic stem cells
Aguila, J. R., Liao, W., Yang, J., Avila, C., Hagag, N. G., Senzel, L. B., & Ma, Y. (2011) · Blood · doi:10.1182/blood-2011-01-333641 · Cited by 91
zu Schwabedissen, H. E. M., & Kroemer, H. K. (2010) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-14541-4_9 · Cited by 89
Wakabayashi, K., Nakagawa, H., Tamura, A., Koshiba, S., Hoshijima, K., Komada, M., & Ishikawa, T. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.c700133200 · Cited by 88
Vlaming, M. L. H., Pala, Z., van Esch, A., Wagenaar, E., de Waart, D. R., van de Wetering, K., van der Kruijssen, C. M. M., Elferink, R. P. J. O., van Tellingen, O., & Schinkel, A. H. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-2940 · Cited by 88
Kim, Y. H., Ishii, G., Goto, K., Ota, S., Kubota, K., Murata, Y., Mishima, M., Saijo, N., Nishiwaki, Y., & Ochiai, A. (2008) · Lung Cancer · doi:10.1016/j.lungcan.2008.10.008 · Cited by 87
Ahmed‐Belkacem, A., Pozza, A., Macalou, S., et al. (2006) · Anti-Cancer Drugs · doi:10.1097/00001813-200603000-00001 · Cited by 86
Correction: Reversal of Multidrug Resistance by Lapatinib
(2008) · Cancer Research · doi:10.1158/0008-5472.can-68-24-cor · Cited by 86
Chua, C. L., Zaiden, N., Chong, K.-H., See, S.-J., Wong, M. C., Ang, B.-T., & Tang, C. (2008) · Journal of neurosurgery · doi:10.3171/jns/2008/109/11/0856 · Cited by 85
Zander, S. A. L., Kersbergen, A. J., van der Burg, E., de Water, N., van Tellingen, O., Gunnarsdottir, S., Jaspers, J. E., Pajic, M., Nygren, A. O. H., Jonkers, J., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-3367 · Cited by 84
Ehata, S., Johansson, E., Katayama, R., Koike, S., Watanabe, A., Hoshino, Y., Katsuno, Y., Komuro, A., Koinuma, D., Kano, M. R., et al. (2010) · Oncogene · doi:10.1038/onc.2010.546 · Cited by 83
Ding, P.-R., Tiwari, A. K., Ohnuma, S., Lee, J. W. K. K., An, X., Dai, C.-L., Lu, Q.-S., Singh, S., Yang, D., Talele, T. T., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0019329 · Cited by 83
de Wolf, C., Jansen, R. S., Yamaguchi, H., de Haas, M., van de Wetering, K., Wijnholds, J., Beijnen, J. H., & Borst, P. (2008) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-0427 · Cited by 78
The Challenge of Exploiting ABCG2 in the Clinic
Robey, R. W., Ieranò, C., Zhan, Z., & Bates, S. E. (2011) · Current Pharmaceutical Biotechnology · doi:10.2174/138920111795163913 · Cited by 78
Tompkins, L. M., Li, H., Li, L., Lynch, C., Xie, Y., Nakanishi, T., Ross, D. D., & Wang, H. (2010) · Biochemical Pharmacology · doi:10.1016/j.bcp.2010.08.016 · Cited by 77
Self-citationHedgehog Pathway Inhibitor HhAntag691 Is a Potent Inhibitor of ABCG2/BCRP and ABCB1/Pgp
Zhang, Y., Laterra, J., & Pomper, M. G. (2009) · Neoplasia · doi:10.1593/neo.81264 · Cited by 76
Asashima, T., Hori, S., Ohtsuki, S., Tachikawa, M., Watanabe, M., Mukai, C., Kitagaki, S., Miyakoshi, N., & Terasaki, T. (2006) · Pharmaceutical Research · doi:10.1007/s11095-006-0067-2 · Cited by 76
Substrate‐dependent bidirectional modulation of P‐glycoprotein‐mediated drug resistance by erlotinib
Noguchi, K., Kawahara, H., Kaji, A., Katayama, K., Mitsuhashi, J., & Sugimoto, Y. (2009) · Cancer Science · doi:10.1111/j.1349-7006.2009.01213.x · Cited by 75
Vlaming, M. L. H., van Esch, A., Pala, Z., Wagenaar, E., van de Wetering, K., van Tellingen, O., & Schinkel, A. H. (2009) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-09-0668 · Cited by 74
Zhao, R., Raub, T. J., Sawada, G. A., Kasper, S. C., Bacon, J. A., Bridges, A. S., & Pollack, G. M. (2009) · Drug Metabolism and Disposition · doi:10.1124/dmd.108.025064 · Cited by 74
Nakagawa, H., Tamura, A., Wakabayashi, K., Hoshijima, K., Komada, M., Yoshida, T., Kometani, S., Matsubara, T., Mikuriya, K., & Ishikawa, T. (2008) · Biochemical Journal · doi:10.1042/bj20071229 · Cited by 73
Katayama, R., Koike, S., Sato, S., Sugimoto, Y., Tsuruo, T., & Fujita, N. (2009) · Cancer Science · doi:10.1111/j.1349-7006.2009.01288.x · Cited by 73
Pregnane X Receptor Protects HepG2 Cells from BaP-Induced DNA Damage
Naspinski, C., Gu, X., Zhou, G.-D., Mertens‐Talcott, S. U., Donnelly, K. C., & Tian, Y. (2008) · Toxicological Sciences · doi:10.1093/toxsci/kfn058 · Cited by 73
Nakanishi, T., Bailey-Dell, K. J., Hassel, B. A., Shiozawa, K., Sullivan, D. M., Turner, J. G., & Ross, D. D. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4572 · Cited by 72
Self-citationBalasubramanian, P., Lamba, J. K., Strom, S. C., Sparreboom, A., Thummel, K. E., Watkins, P. B., & Schuetz, E. G. (2008) · Drug Metabolism and Disposition · doi:10.1124/dmd.107.018366 · Cited by 72
Poller, B., Iusuf, D., Sparidans, R. W., Wagenaar, E., Beijnen, J. H., & Schinkel, A. H. (2011) · Drug Metabolism and Disposition · doi:10.1124/dmd.110.037317 · Cited by 72
Jin, Y., Zhang, Q. B., Huang, Q., Chu, L., Chen, H., Dong, J., Dong, W. A., & Qing, L. (2009) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-009-0578-4 · Cited by 71
Porphyrin Homeostasis Maintained by ABCG2 Regulates Self-Renewal of Embryonic Stem Cells
Susanto, J., Lin, Y., Chen, Y.-N., Shen, C., Yan, Y., Tsai, S., Chen, C., & Shen, C.-N. (2008) · PLoS ONE · doi:10.1371/journal.pone.0004023 · Cited by 71
Pharmacogenomic Importance of ABCG2
Cusatis, G., & Sparreboom, A. (2008) · Pharmacogenomics · doi:10.2217/14622416.9.8.1005 · Cited by 71
Pharmacogenetics of ATP-Binding Cassette Transporters and Clinical Implications
Cascorbi, I., & Haenisch, S. (2009) · Methods in molecular biology · doi:10.1007/978-1-60761-416-6_6 · Cited by 71
Role of BCRP as a biomarker for predicting resistance to 5-fluorouracil in breast cancer
Yuan, J., Lv, H., Peng, B., Wang, C., Yu, Y., & He, Z. (2008) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-008-0838-z · Cited by 70
Stone, R. M., Mazzola, E., Neuberg, D. S., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2014.57.0952 · Cited by 69
Li, J., Li, Z., Du, Y., Li, X., Bao, Q., & Chen, P. (2009) · Clinical Lung Cancer · doi:10.3816/clc.2009.n.078 · Cited by 69
Involvement of drug transporters in the synergistic action of FOLFOX combination chemotherapy
Theile, D., Grebhardt, S., Haefeli, W. E., & Weiß, J. (2009) · Biochemical Pharmacology · doi:10.1016/j.bcp.2009.07.006 · Cited by 69
Lee, O.-H., Xu, J., Fueyo-Margareto, J., et al. (2006) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-06-0184 · Cited by 69
Li, J., Li, Z., Yu, L., Bao, Q., Wu, J.-R., Shi, S.-B., & Li, X. (2009) · Lung Cancer · doi:10.1016/j.lungcan.2009.09.013 · Cited by 68
Suppression of ABCG2 inhibits cancer cell proliferation
Chen, Z., Liu, F., Ren, Q., Zhao, Q., Ren, H., Lu, S., Zhang, L., & Han, Z. (2009) · International Journal of Cancer · doi:10.1002/ijc.24796 · Cited by 68
Antipsychotic Drugs Inhibit the Function of Breast Cancer Resistance Protein
Wang, J., Zhu, H., Markowitz, J. S., Donovan, J. L., Yuan, H., & DeVane, C. L. (2008) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/j.1742-7843.2008.00298.x · Cited by 67
Jeong, H., Cui, W., Yang, Y., Lu, J., He, J., Li, A., Song, D. Y., Guo, Y., Liu, B. H., & Chai, L. (2011) · PLoS ONE · doi:10.1371/journal.pone.0018372 · Cited by 67
Association of multi‐drug resistance gene polymorphisms with pancreatic cancer outcome
Tanaka, M., Okazaki, T., Suzuki, H., Abbruzzese, J. L., & Li, D. (2010) · Cancer · doi:10.1002/cncr.25510 · Cited by 65
Suvannasankha, A., Minderman, H., O’Loughlin, K. L., Nakanishi, T., Ford, L. A., Greco, W. R., Wetzler, M., Ross, D. D., & Baer, M. R. (2004) · British Journal of Haematology · doi:10.1111/j.1365-2141.2004.05211.x · Cited by 63
Self-citationDing, S. (2004) · World Journal of Gastroenterology · doi:10.3748/wjg.v10.i23.3433 · Cited by 62
Solazzo, M., Fantappiè, O., D’Amico, M., Sassoli, C., Tani, A., Cipriani, G., Bogani, C., Formigli, L., & Mazzanti, R. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-4315 · Cited by 61
Fatima, S., Zhou, S., & Sorrentino, B. P. (2011) · Stem Cells · doi:10.1002/stem.1002 · Cited by 60
Gandhi, Y., & Morris, M. E. (2009) · The AAPS Journal · doi:10.1208/s12248-009-9132-1 · Cited by 60
Nicolazzo, J. A., & Katneni, K. (2009) · Current Topics in Medicinal Chemistry · doi:10.2174/156802609787521580 · Cited by 57
Shen, J., Carcaboso, A. M., Hubbard, K. E., Tagen, M., Wynn, H. G., Panetta, J. C., Waters, C. M., Elmeliegy, M. A., & Stewart, C. F. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-0700 · Cited by 57
Upregulation of ABCG2 by Romidepsin via the Aryl Hydrocarbon Receptor Pathway
To, K. K. W., Robey, R. W., Zhan, Z., Bangiolo, L., & Bates, S. E. (2011) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-10-0270 · Cited by 56
Yang, J. J., Milton, M., Yu, S., Liao, M., Liu, N., Wu, J., Gan, L.-S. L., Balani, S. K., Lee, F. W., Prakash, S. R., et al. (2010) · Drug Metabolism Letters · doi:10.2174/187231210792928279 · Cited by 55
Azuma, M. (2009) · International Journal of Oncology · doi:10.3892/ijo_00000337 · Cited by 55
Wakabayashi‐Nakao, K., Tamura, A., Furukawa, T., Nakagawa, H., & Ishikawa, T. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2008.08.008 · Cited by 54
Lack of ABCG2 Expression and Side Population Properties in Human Pluripotent Stem Cells
Zeng, H., Park, J. W., Guo, M., Lin, G., Crandall, L. J., Compton, T., Wang, X., Li, X., Chen, F., & Xu, R. (2009) · Stem Cells · doi:10.1002/stem.192 · Cited by 54
BCRP at the Blood−Brain Barrier: Genomic Regulation by 17β-Estradiol
Mahringer, A., & Fricker, G. (2010) · Molecular Pharmaceutics · doi:10.1021/mp1001729 · Cited by 53
Azzariti, A., Porcelli, L., Simone, G. M., Quatrale, A. E., Colabufo, N. A., Berardi, F., Perrone, R., Zucchetti, M., D’Incalci, M., Xu, J., et al. (2009) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-009-1039-0 · Cited by 52
Cuestas, M. L., Sosnik, A., & Mathet, V. L. (2011) · Molecular Pharmaceutics · doi:10.1021/mp2000132 · Cited by 51
Ning, Z.-F., Huang, Y.-J., Lin, T.-X., Zhou, Y.-X., Jiang, C. L., Xu, K.-W., Huang, H., Yin, X.-B., & Huang, J. (2009) · Journal of International Medical Research · doi:10.1177/147323000903700304 · Cited by 50
Cited by
Getting Across the Cell Membrane: An Overview for Small Molecules, Peptides, and Proteins
Yang, N. J., & Hinner, M. J. (2015) · Methods in Molecular Biology · doi:10.1007/978-1-4939-2272-7_3 · Cited by 826
Targeting Epithelial–Mesenchymal Transition (EMT) to Overcome Drug Resistance in Cancer
Du, B., & Shim, J. (2016) · Molecules · doi:10.3390/molecules21070965 · Cited by 807
Role of the Breast Cancer Resistance Protein (BCRP/ABCG2) in Drug Transport—an Update
Mao, Q., & Unadkat, J. D. (2015) · The AAPS Journal · doi:10.1208/s12248-014-9668-6 · Cited by 670
Deng, Z. J., Morton, S. W., Ben-Akiva, E., Dreaden, E. C., Shopsowitz, K. E., & Hammond, P. T. (2013) · ACS Nano · doi:10.1021/nn4047925 · Cited by 516
Three-Dimensional Structures of Membrane Proteins from Genomic Sequencing
Hopf, T. A., Colwell, L. J., Sheridan, R., Rost, B., Sander, C., & Marks, D. S. (2012) · Cell · doi:10.1016/j.cell.2012.04.012 · Cited by 512
Metadata
- Authors
- Natarajan, K., Xie, Y., Baer, M. R., & Ross, D. D.
- Venue
- Biochemical Pharmacology
- Publisher
- Elsevier BV
- Published
- 2012-04
- Volume
- 83
- Issue
- 8
- Pages
- 1084-1103
- ISSN
- 0006-2952 (ISSN-L)
- OpenAlex
- W1991953785
- Cited by
- 405
- References
- 237
- FWCI
- 19.88
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.